Charles Schwab Investment Management Inc Mannkind Corp Transaction History

Charles Schwab Investment Management Inc

  • $527 Billion
  • Q4 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Mannkind Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,270,106 shares of MNKD stock, worth $12.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,270,106
Previous 2,224,829 2.04%
Holding current value
$12.7 Million
Previous $14 Million 4.47%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
BUY
$5.93 - $7.44 $268,492 - $336,860
45,277 Added 2.04%
2,270,106 $14.6 Million
Q3 2024

Nov 12, 2024
BUY
$5.01 - $6.7 $210,625 - $281,674
42,041 Added 1.93%
2,224,829 $14 Million
Q2 2024

Aug 12, 2024
BUY
$4.05 - $5.43 $247,617 - $331,990
61,140 Added 2.88%
2,182,788 $11.4 Million
Q1 2024

May 08, 2024
BUY
$3.25 - $5.27 $178,113 - $288,817
54,804 Added 2.65%
2,121,648 $9.61 Million
Q4 2023

Feb 06, 2024
BUY
$3.34 - $4.29 $101,646 - $130,557
30,433 Added 1.49%
2,066,844 $7.52 Million
Q3 2023

Nov 08, 2023
BUY
$3.91 - $5.45 $319,611 - $445,493
81,742 Added 4.18%
2,036,411 $8.41 Million
Q2 2023

Aug 09, 2023
BUY
$3.72 - $4.79 $90,347 - $116,334
24,287 Added 1.26%
1,954,669 $7.96 Million
Q1 2023

May 11, 2023
BUY
$3.95 - $5.63 $14,634 - $20,859
3,705 Added 0.19%
1,930,382 $7.91 Million
Q4 2022

Feb 13, 2023
BUY
$3.02 - $5.37 $230,634 - $410,101
76,369 Added 4.13%
1,926,677 $10.2 Million
Q3 2022

Nov 14, 2022
BUY
$2.99 - $4.35 $161,454 - $234,891
53,998 Added 3.01%
1,850,308 $5.72 Million
Q2 2022

Aug 15, 2022
SELL
$2.67 - $4.77 $85,239 - $152,282
-31,925 Reduced 1.75%
1,796,310 $6.84 Million
Q1 2022

May 13, 2022
BUY
$2.62 - $4.45 $150,542 - $255,692
57,459 Added 3.24%
1,828,235 $6.73 Million
Q4 2021

Feb 11, 2022
BUY
$4.05 - $5.37 $137,764 - $182,665
34,016 Added 1.96%
1,770,776 $7.74 Million
Q3 2021

Nov 16, 2021
BUY
$3.89 - $5.48 $106,500 - $150,031
27,378 Added 1.6%
1,736,760 $7.56 Million
Q2 2021

Aug 16, 2021
BUY
$3.61 - $5.45 $265,392 - $400,662
73,516 Added 4.49%
1,709,382 $9.32 Million
Q1 2021

May 17, 2021
BUY
$3.14 - $6.14 $430,603 - $842,008
137,135 Added 9.15%
1,635,866 $6.41 Million
Q4 2020

Feb 16, 2021
BUY
$1.79 - $4.04 $53,073 - $119,786
29,650 Added 2.02%
1,498,731 $4.69 Million
Q3 2020

Nov 13, 2020
BUY
$1.56 - $2.08 $206,247 - $274,996
132,210 Added 9.89%
1,469,081 $2.76 Million
Q2 2020

Aug 14, 2020
BUY
$0.94 - $2.21 $135,700 - $319,040
144,362 Added 12.11%
1,336,871 $2.34 Million
Q1 2020

May 15, 2020
BUY
$0.84 - $1.76 $26 - $54
31 Added 0.0%
1,192,509 $1.23 Million
Q4 2019

Feb 07, 2020
BUY
$1.14 - $1.49 $86,424 - $112,958
75,811 Added 6.79%
1,192,478 $1.54 Million
Q3 2019

Nov 08, 2019
BUY
$1.04 - $1.44 $153,758 - $212,896
147,845 Added 15.26%
1,116,667 $1.4 Million
Q2 2019

Aug 09, 2019
SELL
$1.09 - $1.88 $886 - $1,528
-813 Reduced 0.08%
968,822 $1.12 Million
Q1 2019

May 14, 2019
BUY
$1.14 - $2.25 $157,877 - $311,600
138,489 Added 16.66%
969,635 $1.91 Million
Q4 2018

Feb 14, 2019
BUY
$1.02 - $2.05 $74,293 - $149,315
72,837 Added 9.61%
831,146 $882,000
Q3 2018

Nov 13, 2018
BUY
$1.01 - $2.19 $59,920 - $129,926
59,327 Added 8.49%
758,309 $1.39 Million
Q2 2018

Aug 08, 2018
BUY
$1.59 - $2.38 $716,886 - $1.07 Million
450,872 Added 181.72%
698,982 $1.33 Million
Q1 2018

May 07, 2018
BUY
$2.28 - $3.8 $136,074 - $226,791
59,682 Added 31.67%
248,110 $566,000
Q4 2017

Jan 17, 2018
BUY
$2.28 - $6.71 $161,907 - $476,490
71,012 Added 60.48%
188,428 $438,000
Q3 2017

Nov 13, 2017
BUY
$1.15 - $2.29 $135,028 - $268,882
117,416
117,416 $255,000

Others Institutions Holding MNKD

# of Institutions
255
Shares Held
150M
Call Options Held
1.62M
Put Options Held
802K
View Full List

About MANNKIND CORP

MNKD Quotes by TradingView
  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.44B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email